Research programme: antibiotic therapeutics - Roche/Warp Drive Bio
Latest Information Update: 28 Nov 2021
At a glance
- Originator Roche; Warp Drive Bio
- Class Anti-infectives; Antibacterials; Antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Gram-negative infections
Most Recent Events
- 28 Nov 2021 No recent reports of development identified for research development in Gram-negative-infections in Switzerland
- 28 Nov 2021 No recent reports of development identified for research development in Gram-negative-infections in USA
- 16 Oct 2017 Warp Drive Bio and Roche agree to co-promote and co-develop antibiotics for Gram-negative infections